Zimmer Biomet Holdings, Inc. (ZBH)
$92.08-0.10%Close
SELLRECOVERY · day 1
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $17.8B
- Beta
- 0.48
- Div yield
- 1.04%
- P/E (TTM)
- 22.30
- Short % float
- 5.05%
- Days to cover
- 4.4
- SI change
- +13.6%
- 1W
- +2.68%
- 1M
- -4.36%
- vs SPY 1W
- +2.81%
- vs SPY 1M
- -6.87%
Industry peers
FMP comparable companies · ranked by market cap
- MDTSELLMedtronic Plc$113.3BRECOVERYQ 14$88.48+1.17%
- SYKBUYStryker Corporation$106.3BRECOVERYQ 25$277.33-0.02%
- BSXSELLBoston Scientific Corporation$63.5BRECOVERYQ 6$42.73-1.21%
- EWSELLEdwards Lifesciences Corporation$49.1BBEARQ 18$85.21-1.30%
- GEHCBUYGE HealthCare Technologies Inc.$29.7BRECOVERYQ 7$65.74+1.55%
- PHGSELLKoninklijke Philips N.V.$23.7BRECOVERYQ 10$24.24+0.61%
- TRUMYTerumo Corporation$21.1B$14.28
- SNNSELLSmith & Nephew plc$11.4BRECOVERYQ 15$27.24+0.69%
- ALGNSELLAlign Technology, Inc.$10.2BRECOVERYQ 15$142.71+2.22%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ZBH?
- LOPJLB’s latest quantitative signal on Zimmer Biomet Holdings, Inc. (ZBH) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is ZBH in?
- Zimmer Biomet Holdings, Inc. (ZBH) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Zimmer Biomet Holdings, Inc. (ZBH) do?
- Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Eur…